Purdue Pharma asserts patent infringement claims under Hatch-Waxman Act related to OxyContin® against KVK-Tech and Abhai
Clients Purdue Pharma L.P.
Jones Day is representing Purdue Pharma L.P. in a Hatch-Waxman patent infringement action against defendants, relating to the defendants' submission of an Abbreviated New Drug Application to the FDA seeking approval of generic versions of OxyContin®, a widely prescribed treatment for pain relief.
Purdue Pharma L.P. et al. v. KVK-Tech Inc. and Abhai, LLC, Case No. 1:16-cv-00025-UNA (D. Del)